Volumeer

Volumeer AB is a medical technology company focused on improving the diagnosis of sepsis. The company is developing an instrument designed to standardize and enhance the quality of blood samples taken for microbiological diagnostics. This technology aims to ensure precise sample volumes and reduce contamination, which are critical factors for accurate sepsis detection and subsequent treatment. Sepsis is a major global health issue, identified by the World Health Organization as a global health priority, and is associated with high mortality rates.

The company's approach targets the pre-analytical phase of diagnostics, addressing the unmet need for a standardized method in blood sample collection. By improving the accuracy of the sampling process, Volumeer aims to facilitate faster and more reliable diagnostics for patients, while also potentially reducing the workload for healthcare professionals. The company emphasizes that its solution is designed by healthcare professionals for healthcare professionals, drawing on experience in laboratory diagnostics and close relationships with nursing staff.

Keywords: sepsis diagnostics, blood sample quality, medical device, pre-analytical phase, microbiological diagnostics, sample volume, contamination reduction, healthcare technology, accurate sampling, patient diagnostics